GRIB has a wide experience in the participation and coordination of research projects in the field of Bioinformatics, funded by the European Commission and other research funding agencies. It also has a long tradition of collaboration with the pharmaceutical and biotechnological industry in the framework of R&D projects and providing services, especially in the development of computational methods for drug discovery and toxicity assesment. Some of these companies are listed below:

  • AstraZeneca AB (SE)
  • Boehringer Ingelheim International GmbH (DE)
  • Glaxosmithkline Research and Development LTD (UK)
  • Eli Lilly and Company Ltd (UK)
  • Sanofi Aventis GmbH (DE)
  • F. Hoffmann - La Roche AG (CH)
  • Institut de Recherches Internationales Servier (FR)
  • Lhasa Limited (UK)
  • Molecular Networks GmbH (DE)
  • Novartis Pharma AG (CH)
  • Janssen Pharmaceutica NV (BE)

Some of the Project Consortiums with the participation of GRIB

Site Information